Application 213469
- Type
- ANDA
- Sponsor
- GRANULES PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VIGABATRIN | VIGABATRIN | FOR SOLUTION;ORAL | 500MG/PACKET | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A213469-001 | VIGABATRIN | VIGABATRIN | 500MG/PACKET | FOR SOLUTION / ORAL | 2020-04-24 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A213469-001 | VIGABATRIN | 500MG/PACKET | FOR SOLUTION / ORAL | 2020-04-24 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A213469-001 | AA | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A213469-001 | AA | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A213469-001 | AA | 1 | 4b0b4de00fa7… |
| 2022-03-09 01:35 UTC | 2022-03 | A213469-001 | AA | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A213469-001 | AA | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A213469-001 | AA | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A213469-001 | AA | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A213469-001 | AA | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A213469-001 | AA | 1 | c0c555d07b60… |
| 2022-09-29 23:25 UTC | 2022-09 | A213469-001 | AA | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A213469-001 | AA | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vigabatrin | VIGABATRIN | Edenbridge Pharmaceuticals LLC. | 93ba3894-fd97-4432-9f2d-e7050371e91f | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | Vigabatrin VIGABATRIN |
| VIGADRONE | VIGABATRIN | Upsher-Smith Laboratories, LLC | 5e5e7554-d0f4-47f7-a434-cc5ca5a9826f | 2026-06-15 | Boxed warning, Warnings, Adverse reactions | VIGABATRIN |
| Vigabatrin | VIGABATRIN | Novadoz Pharmaceuticals LLC | 082d818a-4f4e-4675-98c6-91db0294e63c | 2026-06-15 | Boxed warning, Warnings, Adverse reactions | Vigabatrin VIGABATRIN |
| vigabatrin | VIGABATRIN | Carnegie Pharmaceuticals LLC | 8406bd5a-8887-4579-a11e-5ab449c58963 | 2026-02-17 | Boxed warning, Warnings, Adverse reactions | vigabatrin VIGABATRIN |
| VIGABATRIN | VIGABATRIN | Par Health USA, LLC | e7cbc0a5-8c28-4451-9176-b608e228ba66 | 2026-01-20 | Boxed warning, Warnings, Adverse reactions | VIGABATRIN VIGABATRIN |
| vigabatrin | VIGABATRIN | Zydus Lifesciences Limited | cd5ebc7a-8d5b-46b4-ad9b-e4a25fa3e26c | 2025-11-07 | Boxed warning, Warnings, Adverse reactions | vigabatrin VIGABATRIN |
| vigabatrin | VIGABATRIN | Zydus Lifesciences Limited | e9c99000-fc0c-4083-b620-ba9ac821f8ac | 2025-11-07 | Boxed warning, Warnings, Adverse reactions | vigabatrin VIGABATRIN |
| VIGAFYDE | VIGABATRIN | Upsher-Smith Laboratories, LLC | 8d3d6316-33ab-41e8-9485-4495c218be56 | 2025-11-01 | Boxed warning, Warnings, Adverse reactions | VIGABATRIN |
| Vigabatrin | VIGABATRIN | Aurobindo Pharma Limited | c97ce40c-1c5a-479d-9188-5ce03cf7e065 | 2025-07-15 | Boxed warning, Warnings, Adverse reactions | Vigabatrin VIGABATRIN |
| VIGADRONE | VIGABATRIN | Upsher-Smith Laboratories, LLC | 01f7f049-78c2-47c2-a66e-ec662ba48a98 | 2024-11-18 | Boxed warning, Warnings, Adverse reactions | VIGABATRIN |
| Vigabatrin | VIGABATRIN | Actavis Pharma, Inc. | 8dc7bd15-2636-4d58-b651-dd117ca43dbd | 2024-09-30 | Boxed warning, Warnings, Adverse reactions | Vigabatrin VIGABATRIN |
| Vigabatrin | VIGABATRIN | Dr. Reddys Laboratories Inc., | f6be436e-46c7-e9ab-0fcf-e8d04dc12b72 | 2024-06-07 | Boxed warning, Warnings, Adverse reactions | Vigabatrin VIGABATRIN |
| vigabatrin for oral solution | VIGABATRIN | Camber Pharmaceuticals, Inc. | bda491b6-47ba-400b-9816-b6d15c6e2683 | 2024-04-22 | Boxed warning, Warnings, Adverse reactions | VIGABATRIN |
| vigabatrin | VIGABATRIN | Zydus Pharmaceuticals (USA) Inc. | 6d3fc853-1b2d-47ad-a4f2-f11505601bc2 | 2024-03-27 | Boxed warning, Warnings, Adverse reactions | vigabatrin VIGABATRIN |
| vigabatrin | VIGABATRIN | Zydus Pharmaceuticals (USA) Inc. | 6c0bf4fb-b234-4053-9163-1e8d0142d718 | 2024-03-21 | Boxed warning, Warnings, Adverse reactions | vigabatrin VIGABATRIN |
| Vigabatrin | VIGABATRIN | Aurobindo Pharma Limited | 4aaea88b-e0fd-45e3-bb02-604bf8ee9b5b | 2024-01-19 | Boxed warning, Warnings, Adverse reactions | Vigabatrin VIGABATRIN |
| Vigabatrin | VIGABATRIN | Amneal Pharmaceuticals NY LLC | 9791494f-492b-487a-8211-7747fb57923e | 2023-02-28 | Boxed warning, Warnings, Adverse reactions | Vigabatrin VIGABATRIN |
| Vigabatrin | VIGABATRIN | Amneal Pharmaceuticals NY LLC | 5b8fb137-848b-45fd-9107-a6db5a675360 | 2022-12-23 | Boxed warning, Warnings, Adverse reactions | Vigabatrin VIGABATRIN |
| VIGABATRIN | VIGABATRIN | Ascend Laboratories, LLC | ee835fb6-2b2b-40c4-b6d7-0ad0e790cda8 | 2022-11-16 | Boxed warning, Warnings, Adverse reactions | VIGABATRIN VIGABATRIN |
| Vigabatrin | VIGABATRIN | Hikma Pharmaceuticals USA Inc | 5ed8d293-b7d8-4c66-9c31-8075e6f99092 | 2022-08-11 | Boxed warning, Warnings, Adverse reactions | Vigabatrin VIGABATRIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
Documents#
| Document | Submission type | Date |
|---|---|---|
| 76023 | ORIG | 2023-11-01 |